Dr. Amanda Laird, MD is an endocrine surgeon and Chief of Endocrine Surgery at the Rutgers Cancer Institute of New Jersey in New Brunswick, New Jersey. She is currently licensed…
H. Gilbert Welch, MD, MPHAn internationally recognized expert on the effects of medical screening and over-diagnosisDr. Gilbert Welch's work is leading many patients and physicians think carefully about what leads…
En esta entrevista, discutimos los siguientes temas: * Menos función cardiovascular * Hipertensión * La conexión entre el funcionamiento del corazón menos y el hipotiroidismo * El riesgo cardiovascular * Resistencia cardiovascular * Mayor colesterol LDL e hipotiroidismo * Hipotiroidismo subclínico y riesgo * Niveles de TSH * Niveles de TSH por encima de 10 * Colesterol e hipotiroidismo * Riesgo residual y estatinas * Mejorando la absorción de T4 * Levotiroxina y buen cumplimiento * Osteoporosis
In this episode we hear from Doug, and 37 year old, male patient of Hashimoto's. Discussed, are the following topics: • Panic attacks • Nervous • Sweating • Can’t get out of bed • Putting on weight • Feeling coldness • NP Thyroid® • L-Tyrosine • Synthroid • WP Thyroid • WP Thyroid and L-Tyrosine combination therapy • High heart rate on T3
In this interview, the following topics are discussed: * Better treatment options for thyroid disease * Better testing for thyroid disease * Mental challenges * Juggling career and Hashimoto's * The word insignificant * The role of T3 and biological connections * Diagnosed at twelve years old * Disappearing eyebrows
In this episode, we visit with Carla. She had thyroid cancer surgery. During the interview, we discuss: * 50 biopsies of the first nodule * 5 cm nodule * Biopsies * RAI * Weight gain * Support from family
During this episode, the following topics are discussed: 1. Financial burden of surgery versus total cost of active surveillance over ten years. 2. Stretching Exercises for Neck 3. Setting patient expectations prior to FNA to manage anxiety 4. When the laryngeal nerve is severed during thyroid surgery, it can and should be repaired, with proper surgeon skill and training. 5. The most common question asked to Dr. Miyauchi by surgeons from around the world.
In this episode, topics include: * Drug therapy for patients that fail standard therapy; including surgery and RAI * Not all patients have same behavior for their cancer * Some cancers are aggressive * Not many thyroid cancer patients are affected by this; maybe a few thousand in the U.S., but not tens of thousands * What is the treatment protocol for therapy? * Lenvatinib or Sorafenib is the treatment for refectory thyroid cancer * Lenvatinib tends to be more effective * Sorafenib is tolerated by the patient better * Other options to consider include, molecular profiling or some thyroid cancers carry mutation that is targetable, or BRAF * BRAF inhibitors used with thyroid cancer patients * Molecular profiling * DNA sequencing
Kimberly Vanderveen, MD is a Colorado native and graduate of Bear Creek High School in Lakewood, CO. She received her bachelor’s degree with honors from Muhlenberg College in Allentown, PA. She then earned her medical degree from Northwestern University in Chicago, IL in 2001. In this episode, the following topics are discussed: * Two roads of tests: rule out and malignant markers * Rule-out tests picks up innocent behavior pattern. Most common is Afirma * Malignant markers, or rule-in tests, are useful at determining extent of surgery, and help avoid a second or third surgery. ThyroSeq, ThyraMIR, Rosetta * Do patients get both tests? Rule out and behavior? * Approximately 15% of FNA’s come back indeterminate. Some centers as high as 30% * Managing indeterminate nodules when a patient chooses no surgery. * Taking into account emotional, financial, and lifestyle goals of the patient.
Bryan McIver, MD, PhD Dr. McIver contributes to Moffitt Cancer Center almost 20 years of clinical experience in the care of patients with endocrine diseases, specializing in the evaluation of patients with thyroid nodules and thyroid cancer. He has a particular interest in the management of patients with advanced and aggressive forms of cancer and the role of genetic and molecular techniques to improve the accuracy of diagnosis. Most nodules are benign When to do a biopsy How to interpret the results of biopsy Advances in thyroid cancer Ultrasound technology advancements Molecular markers Cytopathology categorizations Molecular marker technologies Gene expression classifier